Single-blind, randomized controlled trial of effectiveness of Naikan therapy as an adjunctive treatment for schizophrenia over a one-year follow-up period

CONCLUSIONS: This study provides robust support for the effectiveness of Naikan therapy as an adjunctive treatment during the recovery period of schizophrenia. Compared to treatment as usually, adjunctive Naikan therapy can sustain the improvement in psychotic symptoms achieved during acute treatment, improve insight about the illness, enhance social functioning, and reduce relapse over a one-year follow-up period. Further research of this treatment with larger and more diverse samples of patients with schizophrenia is merited.

1 Like

Here is more info on this type of therapy. This study is only “single blind” (that is, the researchers knew what “therapy” the study participants and the control group was getting - so it could be biased.

I wonder how it would compare to other standard forms of psychotherapy for people with schizophrenia - e.g. CBT for psychosis, etc.

2 Likes